E-LIB Suche - Ergebnisse für: Salem, Ahmed Hamed

1

Venetoclax Clinical Pharmacokinetics After Administration o..:

Alaei, Samaneh ; Wang, Yamin ; Liu, Yueli...
Clinical Therapeutics. , 2024

Link: https://doi.org/10.1016/..

2

Clinical pharmacokinetics and pharmacodynamics of venetocla..:

Salem, Ahmed Hamed ; Menon, Rajeev M.
Clinical and Translational Science. 17 (2024) 5 - p. , 2024

Link: https://doi.org/10.1111/..

3

Autologous HER2-specific CAR T cells after lymphodepletion ..:

Hegde, Meenakshi ; Navai, Shoba ; DeRenzo, Christopher...
Nature Cancer. 5 (2024) 6 - p. 880-894 , 2024

Link: https://doi.org/10.1038/..

4

Venetoclax pharmacokinetics in participants with end‐stage ..:

Noorani, Behnam ; Menon, Rajeev M. ; Chen, Xin...
British Journal of Clinical Pharmacology. 90 (2023) 3 - p. 748-758 , 2023

Link: https://doi.org/10.1111/..

5

Venetoclax in biomarker‐selected multiple myeloma patients:..:

Badawi, Mohamed ; Coppola, Sheryl ; Eckert, Doerthe...
Hematological Oncology. 42 (2023) 1 - p. , 2023

Link: https://doi.org/10.1002/..

6

Pooled Population Pharmacokinetic Analyses of Venetoclax in..:

Gong, Jingqi Q. X. ; Suleiman, Ahmed A. ; Menon, Rajeev...
The Journal of Clinical Pharmacology. 63 (2023) 8 - p. 950-960 , 2023

Link: https://doi.org/10.1002/..

7

Venetoclax Penetrates the Blood Brain Barrier: A Pharmacoki..:

Badawi, Mohamed ; Menon, Rajeev ; Place, Andrew E....
Journal of Cancer. 14 (2023) 7 - p. 1151-1156 , 2023

Link: https://doi.org/10.7150/..

8

Relationship Between Venetoclax Exposure and Undetectable M..:

Gopalakrishnan, Sathej ; Menon, Rajeev ; Suleiman, Ahmed A....
HemaSphere. 7 (2023) 12 - p. e983 , 2023

Link: https://doi.org/10.1097/..

9

P-229 Exposure-response analysis of venetoclax in combinati..:

Badawi, Mohamed ; Engelhardt, Benjamin ; Dobkowska, Edyta...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S161-S162 , 2023

Link: https://doi.org/10.1016/..

10

Impact of Multiple Concomitant CYP3A Inhibitors on Venetocl..:

Mukherjee, Dwaipayan ; Brackman, Deanna J. ; Suleiman, Ahmed A....
The Journal of Clinical Pharmacology. 63 (2022) 1 - p. 119-125 , 2022

Link: https://doi.org/10.1002/..

11

Pharmacokinetics and Exposure-Response Analysis of Venetocl..:

Samineni, Divya ; Gibiansky, Leonid ; Wang, Bei...
Advances in Therapy. 39 (2022) 8 - p. 3635-3653 , 2022

Link: https://doi.org/10.1007/..

12

Bioavailability Evaluation of Venetoclax Lower-Strength Tab..:

Badawi, Mohamed ; Chen, Xin ; Marroum, Patrick...
Clinical Drug Investigation. 42 (2022) 8 - p. 657-668 , 2022

Link: https://doi.org/10.1007/..

13

Venetoclax exposure‐efficacy and exposure‐safety relationsh..:

Brackman, Deanna ; Eckert, Doerthe ; Menon, Rajeev...
Hematological Oncology. 40 (2022) 2 - p. 269-279 , 2022

Link: https://doi.org/10.1002/..

14

A Critical Review of Chloroquine and Hydroxychloroquine as ..:

Abdel-Aziz, Amal Kamal ; Saadeldin, Mona Kamal ; Salem, Ahmed Hamed...
Future Pharmacology. 2 (2022) 4 - p. 431-443 , 2022

Link: https://doi.org/10.3390/..

15

Phase 2 study of venetoclax plus carfilzomib and dexamethas..:

Costa, Luciano J. ; Davies, Faith E. ; Monohan, Gregory P....
Blood Advances. 5 (2021) 19 - p. 3748-3759 , 2021

Link: https://doi.org/10.1182/..